INSULIN-LIKE GROWTH FACTOR-I AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL IN WOMEN DURING HIGH-FAT AND LOW-FAT FEEDING

被引:15
作者
PREWITT, TE
UNTERMAN, TG
GLICK, R
COLE, TG
SCHMEISSER, D
BOWEN, PE
LANGENBERG, P
机构
[1] UNIV MARYLAND, DEPT EPIDEMIOL & PREVENT MED, BALTIMORE, MD 21201 USA
[2] WASHINGTON UNIV, SCH MED, DEPT MED, LIPID RES CTR, ST LOUIS, MO 63110 USA
[3] VET ADM W SIDE MED CTR, CHICAGO, IL 60680 USA
[4] UNIV ILLINOIS, COLL MED & ASSOCIATED HLTH PROFESS, DEPT NEUROSURG, CHICAGO, IL 60680 USA
[5] UNIV ILLINOIS, COLL MED & ASSOCIATED HLTH PROFESS, DEPT MED, CHICAGO, IL 60680 USA
关键词
INSULIN-LIKE GROWTH FACTORS; SOMATOMEDINS; CHOLESTEROL; APOLIPOPROTEIN; HYPERLIPOPROTEINEMIA;
D O I
10.1093/ajcn/55.2.381
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
In vitro studies suggest that insulin-like growth factor I (IGF-I) may modulate hepatic production and peripheral utilization of lipoproteins. We measured blood concentrations of IGF-I; total, high-density-lipoprotein, and low-density-lipoprotein (LDL) cholesterol; and apolipoproteins in 18 women with above average cholesterol after high- and low-fat diet periods. Total cholesterol fell 6% (P < 0.02) during the low-fat diet because of reduced concentrations of LDL cholesterol (P < 0.01). Serum concentrations of IGF-I were inversely correlated with total and LDL cholesterol and apolipoprotein B during both high-fat (r = -0.676, P < 0.005; r = -0.745, P < 0.001; and r = -0.504, P < 0.04, respectively) and low-fat (r = -0.656, P < 0.005; r- -0.757, P < 0.001; and r = -0.695, P < 0.001, respectively) diets. IGF-I increased with reduced fat intake in obese subjects only. Thus, IGF-I may contribute to the regulation of LDL cholesterol in mildly hypercholesterolemic women but may not mediate the beneficial response to reduced fat intake.
引用
收藏
页码:381 / 384
页数:4
相关论文
共 27 条
[1]   GROWTH-HORMONE INDUCED CHANGES IN POSTHEPARIN PLASMA-LIPOPROTEIN LIPASE AND HEPATIC TRIGLYCERIDE LIPASE ACTIVITIES [J].
ASAYAMA, K ;
AMEMIYA, S ;
KUSANO, S ;
KATO, K .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1984, 33 (02) :129-131
[2]  
BACHORIK PS, 1984, CLIN CHEM, V30, P839
[3]   GROWTH-HORMONE IN THE REGULATION OF HYPERLIPIDEMIA [J].
BLACKETT, PR ;
WEECH, PK ;
MCCONATHY, WJ ;
FESMIRE, JD .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (02) :117-120
[4]   FACTORS CONTROLLING BLOOD-CONCENTRATION OF SOMATOMEDIN-C [J].
CLEMMONS, DR ;
VANWYK, JJ .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1984, 13 (01) :113-143
[5]   LIPID-SYNTHESIS AND LIPOPROTEIN SECRETION BY CHICK LIVER-CELLS IN CULTURE - INFLUENCE OF GROWTH-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I [J].
CUPO, MA ;
CARTWRIGHT, AL .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1989, 94 (02) :355-360
[6]  
DAWSON PA, 1988, J BIOL CHEM, V263, P3372
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]  
FRIEDMAN M, 1970, NATURE, V1, P464
[9]   THE ROLE OF HUMAN GROWTH-HORMONE IN THE REGULATION OF CHOLESTEROL AND BILE-ACID METABOLISM [J].
HEUBI, JE ;
BURSTEIN, S ;
SPERLING, MA ;
GREGG, D ;
SUBBIAH, MTR ;
MATTHEWS, DE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (05) :885-891
[10]   RELATIONSHIP BETWEEN INSULIN-LIKE GROWTH FACTOR-I AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS IN PRIMARY HYPOTHYROIDISM IN WOMEN [J].
HOOGERBRUGGEVANDERLINDEN, N ;
JANSEN, H ;
HULSMANN, WC ;
BIRKENHAGER, JC .
JOURNAL OF ENDOCRINOLOGY, 1989, 123 (02) :341-345